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OBJECTIVE — We aimed to establish the ideal injection techniques using 5-mm needles to
reliably inject insulin into the subcutaneous fat in both children and adults and to quantify the
associated pain and leakage of the test medium.
RESEARCH DESIGN AND METHODS — A total of 259 subjects (122 children/
adolescentsand137adults)wereinjectedwithsterileaircorrespondingto20IUinsulin(200l)
with32-G5-mmneedlesat90°or45°,intheabdomenandthigh,andwithorwithoutapinched
skin fold. Injection depth was assessed via ultrasonography. Subjects rated pain on a visual
analog scale. Test medium injections into the abdomen and thigh (0.2–0.6 ml) were also
administered to assess injection leakage.
RESULTS — Among children, 5.5% of injections were intramuscular (IM) and 0.5% were
intradermal, while in adults, the incidence was 1.3 and 0.6%, respectively. The frequency of IM
injections was greater in boys and negligible among adult women. Subcutaneous fat thickness
was the primary predictor of the likelihood of IM injections (P  0.001). A third of all patients
reported experiencing no pain during insulin injection, with children/adolescents experiencing
considerably more discomfort than adults. Some leakage of medium was observed, but was
unrelated to injection volume and was generally minimal.
CONCLUSIONS — 5-mm needles are reliably inserted into subcutaneous fat in both adults
and children. These needles were associated with reduced pain and minimal leakage. We rec-
ommendanangledinjectionwithapinchedskinfoldforchildren,whileinadults,thetechnique
should be left to patient preference.
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lthough there are many new tech-
nologies assisting in diabetes care,
multipledailyinjectionsremainthe
mainstay of therapy where insulin is re-
quired.Suchinjectionsaimtoreliablyde-
posit insulin into subcutaneous fat while
minimizing inadvertent intramuscular
(IM) injections (1). Intramuscular injec-
tions of regular, NPH, and glargine insu-
linhavebeenassociatedwithvariabilityin
glycemic control and an increased risk of
severe hypoglycemia (2–6). Although no
studies have systematically evaluated the
frequency of IM injections among dia-
betic patients, these appear to be rela-
tively common (6,7).
The risk of IM insulin deposition is
associated with a number of factors in-
cluding younger age, male sex, lower
BMI, injection technique (angle of inser-
tionandaliftedorpinchedskinfold),and
needlelength(5,8–11).Furthermore,the
thinner a person’s skin or subcutaneous
fat layer, the greater the chances of an ac-
cidental IM injection (5). Little informa-
tion is known about skin thickness,
although it appears to vary with age, obe-
sity, and puberty (1).
Not surprisingly, needle length has
been shown to be an important variable
determining site of insulin deposition
(5,12).However,althoughdecreasingthe
length of the insulin needle reduces the
incidence of IM injections, the use of
5-mm needles may result in insulin being
administered too superﬁcially in the der-
mallayer(13,14).Theconsequenceofin-
tradermal insulin deposition is largely
unknown, but may lead to increased im-
mune response, injection pain, and insu-
lin leakage (14).
Despite this, there have been few
studies examining injection technique.
Perpendicular insertion of 6-, 8- and
12.7-mm needles has been associated
with frequent IM injections in children
and adolescents with rates of 42, 38, and
86%,respectively(1,5,8).Byusinganan-
gledinsertionof6-mmneedles,theriskof
IM injections was markedly reduced (1).
More recently, 4-mm needles inserted
verticallywereshowntobesafeandeffec-
tive in the majority of lean children and
adults (12). However, no evidence-based
recommendations exist for 5-mm nee-
dles, which are being used with increas-
ing frequency. Although there are some
data on children with other needle
lengths (1,5,8), little information is avail-
able on adults, and it remains unclear
how suitable shorter needles are for this
group, especially for the obese.
Our primary aim was to establish the
ideal injection techniques required to re-
liablyinjectinsulinintothesubcutaneous
fat in both children and adults using
5-mm needles. We also aimed to assess
the level of discomfort associated with
each technique and quantify the respec-
tive amounts of backﬂow or leakage of
test medium to the skin surface.
RESEARCH DESIGN AND
METHODS— Otherwise healthy
children and adolescents with type 1 dia-
betes aged 5–19 years were recruited
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dren’s Hospital, Auckland, New Zealand.
Adults with type 1 and type 2 diabetes
aged between 20 and 85 years were also
recruited. Exclusion criteria included
moderate-to-severe lipohypertrophy,
other medical conditions such as celiac
disease or autoimmune thyroid disease,
associated syndromes (e.g., Down’s syn-
drome), and other secondary causes of
diabetes (e.g., cystic ﬁbrosis). Lipohyper-
trophy was assessed clinically, and, in
those subjects who demonstrated mild li-
pohypertrophy, no injections were made
into areas where any adipose thickening
was noted. Young subjects had weight
and height measured and pubertal status
recorded by a pediatric endocrinologist
(P.L.H. or T.E.P.).
All subjects were injected with sterile
air corresponding to 20 IU insulin (200
l) with NovoFine 32-G 5-mm needles
(Novo Nordisk, Copenhagen, Denmark)
using NovoPen 4 pens (Novo Nordisk).
Eight injections were administered either
perpendicularlyorat45°,intheabdomen
and thigh, and with or without a pinched




chine and a 17.0-MHz linear array
transducer (1). The ultrasound site of the
injected air was assessed as intradermal,
subcutaneousfat,orIM.Inaddition,after
eachinjection,subjectswereaskedtorate
the injection pain on a facial and visual
analog scale (15), with pain response
measured in millimeters.
Subjects were also injected with test
medium(insulin-freediluent)usingFlex-
Pen (Novo Nordisk A/S). Injection vol-
umes of 200, 400, and 600 l were tested
(equivalent to 20, 40, and 60 units of in-
sulin). Using known unit doses of the di-
luents,milligramdoseswereconvertedto
units (slope: 0.1 mg  10 l; r  0.98).
Four injections were made using either a
perpendicular or angled insertion and
with a pinched skin fold into either the
abdomen or lateral thigh. All injections
were given by two experienced diabetes
nurse specialists while the patient was su-
pine, and the needle was withdrawn after
aslowcounttosix.After20–30s,thearea
was gently wiped with tissue paper and
weighed using scientiﬁc scales (accurate
to 10 g).
Ethical approval was received from
the Auckland Ethics Committee, and in-
formed written consent was obtained
from all parents and older subjects. In
younger subjects, oral consent was also
obtained.
General linear regression models
were used to compare the demographic
characteristics of the subjects between
sex, using age as a covariate. Generalized
linear mixed models were used to inves-
tigate the associations between the out-
comes from the injections and the site
(thigh or abdomen), angle (45° or 90°),
and pinching (unpinched or pinched).
Thepersonwastreatedasarandomeffect
toallowforthecorrelationsbetweenmea-
surements on the same subject. Factors
including age, sex, BMI standard devia-
tionscore(BMISDS),skinthickness,sub-
cutaneous fat thickness, and pubertal
status (for children) were included in the
models where appropriate. A logit link
was used for binary outcomes namely: IM
injection (yes/no), leakage (yes/no), and
pain (yes/no). The level of pain was only
investigated within the group who had
pain. Percentages and means are pre-
sented to give an estimate of effect
magnitude.
RESULTS— There were 259 subjects
includedinthisstudy,including122chil-
dren/adolescents and 137 adults (Table
1). The detailed demographic data are
shown in Table 1. Skin thickness varied
minimally with sex and age, although
thigh skin thickness in adult males was
10% greater than in females (P  0.05,
Table 1). The mean BMI steadily in-
creased with age in both males and fe-
males,andconsequentlythesamepattern
was observed for subcutaneous fat. Ab-
dominal subcutaneous fat thickness was
notsigniﬁcantlydifferentbetweenprepu-
bertal boys and girls, but it was 42% (P 
0.01) and 30% (P  0.01) greater in fe-
male than in male adolescents and adults,
respectively. This sex difference was par-
ticularly pronounced in thigh subcutane-
ousfat,whichwasthickerinfemalesthan
males by 49% before puberty (P  0.05),
73% in adolescence (P  0.001), and
95% in adulthood (P  0.001) (Table 1).
A total of 2,072 injections were ad-
ministered: 976 to children/adolescents
and 1,096 to adults (Table 2). Among
children,relativelyfewinjectionswerein-
serted outside subcutaneous fat irrespec-
tive of the site and technique used for
administration, with 54 IM (5.5%) and 5
intradermal (0.5%) injections recorded.
The incidence of IM injections among
adults was even lower, and 14 IM (1.3%)
and7intradermal(0.6%)administrations
were recorded (Table 2).
Note that there were no adverse side
effects associated with the injections ad-
ministeredtothesubject.Inparticular,no
bleeding or bruising was observed.
Table 1—Demographics of the studied population
Children Adolescents Adults
Girls Boys Girls Boys Women Men
n 17 (44) 22 (56) 39 (47) 44 (53) 78 (57) 59 (43)
Age (years) 8.6  1.2 8.6  1.3 14.1  2.7 14.0  2.0 45.4  13.9 44.3  13.9
BMI — — — — 28.5  7.0 27.3  5.2
BMI SDS 0.79  1.16 0.52  1.02 1.0  1.1 1.1  1.0 — —
BMI 85% or 27 kg/m
2* 5 (29) 6 (27) 15 (38) 23 (53) 40 (51) 26 (44)
BMI 95% or 30 kg/m
2* 3 (18) 3 (14) 8 (20) 14 (33) 32 (41) 13 (22)†
Abdominal skin thickness (mm) 1.5  0.3 1.5  0.4 2.0  0.4 2.1  0.7 2.0  0.5 2.1  0.4
Abdominal subcutaneous fat (mm) 8.9  5.0 7.6  4.1 15.5  9.4 10.9  6.2‡ 21.9  11.2 16.9  9.1‡
Thigh skin thickness (mm) 1.3  0.5 1.3  0.3 1.7  0.4 1.7  0.4 1.7  0.6 1.9  0.4†
Thigh subcutaneous fat (mm) 11.0  6.7 7.4  3.7† 14.0  7.3 8.1  3.1§ 18.1  9.5 9.3  3.9§
Data are n (%) or means  SD. *BMI 85% and 95% centiles apply to children, whereas BMI 27 kg/m
2 and 30 kg/m
2 refer to adults. †P  0.05, ‡P  0.01,
§P  0.001 for between-sex comparisons.
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There was a signiﬁcant association be-
tween age and the likelihood of an IM in-
jection (P  0.01), which was much less
frequent among adults (Table 2). Despite
the relatively small number of IM injec-
tions, analyses showed clear sex differ-
ences in the incidence of IM injections
among children and adolescents (Table
3). In prepubertal boys, site made no dif-
ference, but angled and pinched injection
appeared to reduce IM incidence (Table
3). Among girls, no IM deposition was
recorded when the skin was pinched or
the injection was applied to the thigh.
Among adolescents, injection technique
did not affect the frequency of IM admin-
istration, and no IM injections were re-
cordedduringthighinjectionsinfemales.
Such sex differences were more marked
among adults, and the incidence of IM
injections among women was negligible.
In the abdomen, pinched angled injec-
tions are also likely to decrease the likeli-
hood of an IM injection occurring (Table
3). Subcutaneous fat thickness was the
primary predictor of the likelihood of IM
injections (P  0.001) and likely ac-
counted for the sex differences (Table 1).
Pain
Approximately one-third of all patients
reported experiencing no pain during in-
sulin injection (32% children and 31%
adults). The angle or site of injection had
no bearing on whether the subject expe-
rienced pain or not. Among subjects who
experienced pain, children/adolescents
experienced considerably more discom-
fort than adults (20.9  0.8 vs. 14.1 
0.7 mm, respectively; P  0.001). In ad-
dition, abdominal injections were less
painful than those applied to the thigh
(16.2  0.6 vs. 18.8  0.6 mm, respec-
tively; P  0.001).
Leakage
Injections in adults were more likely to
lead to leakage than those given to
younger subjects (70% with detectable
leakage among adults vs. 56% among
children/adolescents, P  0.01). The vol-
ume of medium given (200, 400, or 600
l)didnotaffectthelikelihoodofleakage
occurring (P  0.41). However, leakage





Technique Intradermal Subcutaneous fat IM Intradermal Subcutaneous fat IM
Unpinched
Abdominal
45° 0 113 (92.6) 9 (7.4) 1 (1) 135 (98.5) 1 (0.7)
Vertical 1 (1) 111 (91.0) 10 (8.2) 1 (1) 134 (97.8) 2 (1.5)
Thigh
45° 1 (1) 119 (97.5) 2 (1.6) 0 136 (99.3) 1 (0.7)
Vertical 0 110 (90.2) 12 (9.8) 0 131 (95.6) 6 (4.4)
Pinched
Abdominal
45° 1 (1) 111 (91.0) 10 (8.2) 1 (1) 136 (99.3) 0
Vertical 1 (1) 115 (94.3) 6 (4.9) 2 (1) 135 (98.5) 0
Thigh
45° 0 119 (97.5) 3 (2.5) 2 (1) 134 (97.8) 1 (0.7)
Vertical 1 (1) 119 (97.5) 2 (1.6) 0 134 (97.8) 3 (2.2)
Total 5 (0.5) 917 (94.0) 54 (5.5) 7 (0.6) 1,075 (98.1) 14 (1.3)
Data are n (%).
Table 3—Frequency of IM injections according to sex and pubertal status
Children Adolescents Adults
Girls Boys Girls Boys Females Males
Total injections 136 176 312 352 624 472
IM injections 5 (3.6) 16 (9.1) 8 (2.6) 25 (7.1) 1 (0.2) 13 (2.8)
Site
Abdomen 5 (7.4) 8 (9.1) 8 (5.1) 14 (8.0) 1 (0.3) 2 (0.8)
Thigh 0 8 (9.1) 0 11 (6.3) 0 11 (4.7)
Angle
45° 2 (2.9) 5 (5.6) 5 (3.2) 12 (6.8) 0 3 (1.3)
Vertical 3 (4.4) 11 (12.5) 3 (1.9) 13 (7.4) 1 (0.3) 10 (4.2)
Technique
Unpinched 5 (7.4) 10 (11.4) 4 (2.6) 14 (8.0) 1 (0.3) 9 (3.8)
Pinched 0 6 (6.8) 4 (2.6) 11 (6.3) 0 4 (1.7)
Data are N or n (%).
IM insulin injection and 5-mm needle technique
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(66% to thigh and 58% to abdomen, P 
0.001). Nonetheless, the amount of leak-
age recorded in each case was generally
minimal,amountingtotheequivalentofa
fraction of a unit (Table 4).
CONCLUSIONS — This study dem-
onstrated that 32-G 5-mm needles can be
reliably inserted into subcutaneous fat,
are relatively pain free, and are associated
with minimal leakage from the injection
site. Previous studies using 6-, 8-, and
12.7-mmneedleshavedemonstratedthat
injection technique is important in deter-
mining injection depth (1,5,8). These
data indicated that, in children, 8-mm
needles have an unacceptable rate of IM
injections.Even6-mmneedleshadahigh
rate of IM injections when inserted verti-
cally, although none were reported with
an angled insertion (1). It was thus rec-
ommended that 6-mm needles should be
inserted at an angle in children and
should be preferred to 8-mm needles in
leaner children at higher risk of IM
injections.
The current investigation examined
severaldifferentparadigmsinvolvingnee-
dle insertion with 5-mm needles. Al-
though all paradigms used resulted in the
majority of injections correctly sited in
subcutaneous fat, it is of concern that
some techniques led to 10% of insulin in-
jections being intramuscular in young
subjects. There was an expected reduc-
tion in IM injections using a pinched skin
fold and angled insertion in prepubertal
children,andthiscombinationappearsto
result in the most reliable insertion into
subcutaneous fat in children and lean
adults. In adolescents and adults (espe-
cially women), unless they are particu-
larly thin, any of the injection paradigms
used would be acceptable and the tech-
nique should be based on patient
preference.
Discomfort and pain were remark-
ably low in this study. We observed no
signiﬁcant difference in pain perception
between 45° and 90° injections, which is
consistent with previous ﬁndings (16).
Needle pain is directly related to needle
diameter, and the study needle used is
one of the thinnest commercially avail-
able. While not directly comparable, a
previous study using the same methodol-
ogy resulted in signiﬁcantly higher pain
scores for both 31-G 6-mm and 30-G
8-mm needles insertion, and it was our
experience that the 32-G 5-mm needles
were somewhat less painful (1). It is
worthnotingthatamongindividualswho
experience discomfort, children had
higher scores than adults. Needle aver-
sion and phobia appear to be common in
children with diabetes (17), and pain as-
sociated with daily injections is said to be
important in discouraging patients to ad-
here to treatment (18). Thus, less painful
injections would probably help with the
acceptance and tolerability of insulin
therapy, potentially leading to increased
treatment compliance.
Possible concerns regarding smaller
needles include greater insulin leakage or
back ﬂow. This issue was assessed in a
previousstudyofleanchildrenandadults
using 4-mm needles, and such problems
were not observed. In our study and in
doses up to 0.6 ml (equivalent to 60 units
insulin), we similarly demonstrated min-
imal leakage. Although greater in the
thigh and with perpendicular needle in-
sertion, leakage (when present) was usu-
ally very small. All injections were
administered while the patient was su-
pineand,althoughunlikely,itisnonethe-
less possible that more leakage would
haveoccurredinasittingpositionorwith
a ﬂexed leg.
In summary, we have demonstrated
in both adults and children that 5-mm
needles can reliably be inserted into sub-
cutaneous fat. In children, our ﬁndings
indicate that an angled approach with a
pinched skin fold should be used. In
adults, the technique should be left to pa-
tient preference. The reduced incidence
ofpainobservedwiththeuseofthesenee-
dles in comparison to previous studies
may improve compliance issues, espe-
cially in children, although this will re-
quire further study. Finally, there is
evidence that no substantial back ﬂow or
leakageoccursfromusingshorterneedles
in doses up to 60 units.
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